Option Care Health, Inc. (NASDAQ:OPCH) Forecasted to Post Q3 2024 Earnings of $0.31 Per Share

Option Care Health, Inc. (NASDAQ:OPCH) – Investment analysts at William Blair lowered their Q3 2024 EPS estimates for shares of Option Care Health in a research note issued on Wednesday, April 24th. William Blair analyst M. Larew now expects that the company will earn $0.31 per share for the quarter, down from their previous forecast of $0.32. The consensus estimate for Option Care Health’s current full-year earnings is $1.18 per share. William Blair also issued estimates for Option Care Health’s Q4 2024 earnings at $0.35 EPS.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $0.04. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The firm had revenue of $1.15 billion during the quarter, compared to analysts’ expectations of $1.10 billion. During the same quarter last year, the company posted $0.21 EPS. The firm’s quarterly revenue was up 12.8% on a year-over-year basis.

OPCH has been the subject of several other research reports. Jefferies Financial Group raised their price target on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research report on Monday, March 4th. Barrington Research reiterated an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a report on Wednesday.

Option Care Health Trading Up 1.1 %

NASDAQ OPCH opened at $29.61 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77. The firm has a market cap of $5.15 billion, a price-to-earnings ratio of 19.48, a PEG ratio of 1.43 and a beta of 1.22. The firm has a 50 day simple moving average of $31.96 and a 200-day simple moving average of $31.48. Option Care Health has a one year low of $24.23 and a one year high of $35.74.

Institutional Trading of Option Care Health

Institutional investors have recently modified their holdings of the stock. Wellington Management Group LLP boosted its holdings in shares of Option Care Health by 157.1% in the fourth quarter. Wellington Management Group LLP now owns 7,445,556 shares of the company’s stock valued at $250,841,000 after acquiring an additional 4,549,164 shares during the period. Vanguard Group Inc. boosted its holdings in Option Care Health by 11.8% in the 3rd quarter. Vanguard Group Inc. now owns 19,319,352 shares of the company’s stock valued at $624,981,000 after purchasing an additional 2,037,162 shares in the last quarter. Third Point LLC grew its holdings in Option Care Health by 55.7% during the third quarter. Third Point LLC now owns 5,450,659 shares of the company’s stock worth $176,329,000 after acquiring an additional 1,950,659 shares during the period. Norges Bank purchased a new stake in shares of Option Care Health during the 4th quarter worth $64,343,000. Finally, Assenagon Asset Management S.A. purchased a new position in shares of Option Care Health in the 3rd quarter valued at about $36,239,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of the stock in a transaction dated Monday, February 26th. The stock was acquired at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the transaction, the director now owns 269,528 shares in the company, valued at approximately $8,503,608.40. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.